|
1
|
Maretty-Nielsen K: Prognostic factors in
soft tissue sarcoma. Dan Med J. 61(B4957)2014.PubMed/NCBI
|
|
2
|
Nakamura T, Matsumine A, Matsubara T,
Asanuma K, Uchida A and Sudo A: Clinical significance of
pretreatment serum C-reactive protein level in soft tissue sarcoma.
Cancer. 118:1055–1061. 2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Nakamura T, Matsumine A, Matsubara T,
Asanuma K, Uchida A and Sudo A: The combined use of the
neutrophil-lymphocyte ratio and C-reactive protein level as
prognostic predictors in adult patients with soft tissue sarcoma. J
Surg Oncol. 108:481–485. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Choi ES, Kim HS and Han I: Elevated
preoperative systemic inflammatory markers predict poor outcome in
localized soft tissue sarcoma. Ann Surg Oncol. 21:778–785.
2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Warburg O: On the orign of cancer cells.
Science. 123:309–314. 1956.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Markert CL: Lactate dehydrogenase.
Biochemistry and function of lactate dehydrogenase. Cell Biochem
Funct. 2:131–134. 1984.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gallo M, Sapio L, Spina A, Naviglio D,
Calogero A and Naviglio S: Lactic dehydrogenase and cancer: An
overview. Front Biosci (Landmark Ed). 20:1234–1249. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Huijgen HJ, Sanders GTB, Koster RW,
Vreeken J and Bossuyt PMM: The clinical value of lactate
dehydrogenase in serum: A quantitative review. Clin Chem Lab Med.
35:569–580. 1997.PubMed/NCBI
|
|
10
|
Zhang J, Yao YH, Li BG, Yang Q, Zhang PY
and Wang HT: Prognostic value of pretreatment serum lactate
dehydrogenase level in patients with solid tumors: A systematic
review and meta-analysis. Sci Rep. 5(9800)2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ferrari S, Bacci G, Picci P, Mercuri M,
Briccoli A, Pinto D, Gasbarrini A, Tienghi A and Brach del Prever
A: Long-term follow-up and post-relapse survival in patients with
nonmetastatic osteosarcoma of the extremity treated with
neoadjuvant chemotherapy. Ann Oncol. 8:765–771. 1997.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Durnali A, Alkis N, Cangur S, Yukruk FA,
Inal A, Tokluoglu S, Seker MM, Bal O, Akman T, Inanc M, et al:
Prognostic factors for teenage and adult patients with high-grade
osteosarcoma: An analysis of 240 patients. Med Oncol.
30(624)2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chen J, Sun MX, Hua YQ and Cai ZD:
Prognostic significance of serum lactate dehydrogenase level in
osteosarcoma: A meta-analysis. J Cancer Res Clin Oncol.
140:1205–1210. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Riley RD, Burchill SA, Abrams KR, Heney D,
Sutton AJ, Jones DR, Lambert PC, Young B, Wailoo AJ and Lewis IJ: A
systematic review of molecular and biological markers in tumours of
the Ewing's sarcoma family. Eur J Cancer. 39:19–30. 2003.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Bacci G, Forni C, Longhi A, Ferrari S,
Donati D, De Paolis M, Barbieri E, Pignotti E, Rosito P and Versari
M: Long-term outcome for patients with non-metastatic Ewing's
sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402
patients treated at Rizzoli between 1972 and 1992. Eur J Cancer.
40:73–83. 2004.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wan W, Lou Y, Hu Z, Wang T, Li J, Tang Y,
Wu Z, Xu L, Yang X, Song D and Xiao J: Factors affecting survival
outcomes of patients with non-metastatic Ewing's sarcoma family
tumors in the spine: A retrospective analysis of 63 patients in a
single center. J Neurooncol. 131:313–320. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Fujibuchi T, Miyawaki J, Kidani T, Imai H
and Miura H: Prediction of soft tissue sarcoma from clinical
characteristics and laboratory data. Cancers (Basel).
12(679)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zagars GK, Ballo MT, Pisters PWT, Pollock
RE, Patel SR, Benjamin RS and Evans HL: Prognostic factors for
patients with localized soft-tissue sarcoma treated with
conservation surgery and radiation therapy: An analysis of 1225
patients. Cancer. 97:2530–2543. 2003.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Maretty-Nielsen K, Aggerholm-Pedersen N,
Safwat A, Jørgensen PH, Hansen BH, Baerentzen S, Pedersen AB and
Keller J: Prognostic factors for local recurrence and mortality in
adult soft tissue sarcoma of the extremities and trunk wall. Acta
Orthop. 85:323–332. 2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Biau DJ, Ferguson PC, Turcotte RE, Chung
P, Isler MH, Riad S, Griffin AM, Catton CN, O'Sullivan B and Wunder
JS: Adverse effect of older age on the recurrence of soft tissue
sarcoma of the extremities and trunk. J Clin Oncol. 29:4029–4035.
2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Papworth KE, Arroyo VM, Styring E, Zaikova
O, Melin BS and Lupo PJ: Soft-tissue sarcoma in adolescents and
young adults compared with older adults: A report among 5000
patients from the Scandinavian Sarcoma Group Central Register.
Cancer. 125:3595–3602. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang X, Liu S and Zhao X, Fang E and Zhao
X: The value of C-reactive protein as an independent prognostic
indicator for disease-specific survival in patients with soft
tissue sarcoma: A meta-analysis. PLoS One.
14(e0219215)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Idowu OK, Ding Q, Taktak AFG, Chandrasekar
CR and Yin Q: Clinical implication of pretreatment neutrophil to
lymphocyte ratio in soft tissue sarcoma. Biomarkers. 17:539–544.
2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Liu G, Ke LC and Sun SR: Prognostic value
of pretreatment neutrophil-to-lymphocyte ratio in patients with
soft tissue sarcoma: A meta-analysis. Medicine (Baltimore).
97(e12176)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Li Y, Liu X, Zhang J and Yao W: Prognostic
role of elevated preoperative systemic inflammatory markers in
localized soft tissue sarcoma. Cancer Biomarkers. 16:333–342.
2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Liang Y, Wang W, Que Y, Guan Y, Xiao W,
Fang C, Zhang X and Zhou Z: Prognostic value of the
fibrinogen/albumin ratio (FAR) in patients with operable soft
tissue sarcoma. BMC Cancer. 18(942)2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Szkandera J, Gerger A, Liegl-Atzwanger B,
Stotz M, Samonigg H, Ploner F, Stojakovic T, Leithner A and Pichler
M: Pre-Treatment anemia is a poor prognostic factor in soft tissue
sarcoma patients. PLoS One. 9(e107297)2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li S, Yang Q, Wang H, Wang Z, Zuo D, Cai Z
and Hua Y: Prognostic significance of serum lactate dehydrogenase
levels in Ewing's sarcoma: A meta-analysis. Mol Clin Oncol.
5:832–838. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Miao P, Sheng S, Sun X, Liu J and Huang G:
Lactate dehydrogenase a in cancer: A promising target for diagnosis
and therapy. IUBMB Life. 65:904–910. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
30
|
Shinohara N, Nonomura K, Abe T, Maruyama
S, Kamai T, Takahashi M, Tatsugami K, Yokoi S, Deguchi T, Kanayama
H, et al: A new prognostic classification for overall survival in
asian patients with previously untreated metastatic renal cell
carcinoma. Cancer Sci. 103:1695–1700. 2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wan XB, Wei L, Li H, Dong M, Lin Q, Ma XK,
Huang PY, Wen JY, Li X, Chen J, et al: High pretreatment serum
lactate dehydrogenase level correlates with disease relapse and
predicts an inferior outcome in locally advanced nasopharyngeal
carcinoma. Eur J Cancer. 49:2356–2364. 2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Weide B, Richter S, Büttner P, Leiter U,
Forschner A, Bauer J, Held L, Eigentler TK, Meier F and Garbe C:
Serum S100B, lactate dehydrogenase and brain metastasis are
prognostic factors in patients with distant melanoma metastasis and
systemic therapy. PLoS One. 8(e81624)2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Halabi S, Lin CY, Kelly WK, Fizazi KS,
Moul JW, Kaplan EB, Morris MJ and Small EJ: Updated prognostic
model for predicting overall survival in first-line chemotherapy
for patients with metastatic castration-resistant prostate cancer.
J Clin Oncol. 32:671–677. 2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Mekenkamp LJ, Heesterbeek KJ, Koopman M,
Tol J, Teerenstra S, Venderbosch S, Punt CJ and Nagtegaal ID:
Mucinous adenocarcinomas: Poor prognosis in metastatic colorectal
cancer. Eur J Cancer. 48:501–509. 2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Wang X, Jiang R and Li K: Prognostic
significance of pretreatment laboratory parameters in combined
small-cell lung cancer. Cell Biochem Biophys. 69:633–640.
2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Nakamura T, Asanuma K, Hagi T and Sudo A:
Is serum lactate dehydrogenase useful for predicting oncological
outcome in patients with soft tissue sarcoma? Anticancer Res.
39:6871–6875. 2019.PubMed/NCBI View Article : Google Scholar
|
